Free Trial

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Position in American Healthcare REIT, Inc. (NYSE:AHR)

American Healthcare REIT logo with Finance background

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 115.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 767,365 shares of the company's stock after purchasing an additional 410,868 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.50% of American Healthcare REIT worth $21,809,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Richardson Capital Management LLC bought a new position in shares of American Healthcare REIT in the fourth quarter valued at approximately $29,000. Fifth Third Bancorp bought a new position in shares of American Healthcare REIT in the fourth quarter valued at approximately $39,000. Indiana Trust & Investment Management Co bought a new position in shares of American Healthcare REIT in the fourth quarter valued at approximately $57,000. Assetmark Inc. grew its holdings in shares of American Healthcare REIT by 330.8% in the fourth quarter. Assetmark Inc. now owns 2,615 shares of the company's stock valued at $74,000 after acquiring an additional 2,008 shares in the last quarter. Finally, Promus Capital LLC bought a new position in shares of American Healthcare REIT in the fourth quarter valued at approximately $86,000. 16.68% of the stock is owned by hedge funds and other institutional investors.

American Healthcare REIT Stock Performance

Shares of NYSE:AHR traded up $0.15 during trading on Friday, hitting $34.99. 2,615,147 shares of the company were exchanged, compared to its average volume of 1,866,190. The company has a market cap of $5.58 billion, a PE ratio of -72.90, a P/E/G ratio of 1.57 and a beta of 1.40. The stock has a 50 day moving average of $31.79 and a 200 day moving average of $29.71. American Healthcare REIT, Inc. has a 52-week low of $14.32 and a 52-week high of $35.97. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.37 and a quick ratio of 0.37.

American Healthcare REIT (NYSE:AHR - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.01. The firm had revenue of $540.60 million for the quarter, compared to the consensus estimate of $542.32 million. American Healthcare REIT had a negative return on equity of 1.87% and a negative net margin of 1.84%. The business's quarterly revenue was up 8.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.30 earnings per share. As a group, equities research analysts predict that American Healthcare REIT, Inc. will post 1.41 EPS for the current year.

American Healthcare REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, April 17th. Investors of record on Monday, March 31st were given a $0.25 dividend. The ex-dividend date was Monday, March 31st. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.86%. American Healthcare REIT's dividend payout ratio (DPR) is presently -370.37%.

Analysts Set New Price Targets

Several research firms have recently issued reports on AHR. Jefferies Financial Group began coverage on American Healthcare REIT in a report on Monday, April 28th. They issued a "buy" rating and a $37.00 target price for the company. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $34.00 target price on shares of American Healthcare REIT in a report on Wednesday, March 19th. JMP Securities set a $35.00 price objective on American Healthcare REIT in a report on Tuesday, March 4th. Morgan Stanley increased their price objective on American Healthcare REIT from $37.00 to $45.00 and gave the company an "overweight" rating in a report on Tuesday, May 20th. Finally, KeyCorp reduced their price objective on American Healthcare REIT from $35.00 to $34.00 and set an "overweight" rating for the company in a report on Monday, March 31st. Eight analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $35.00.

View Our Latest Stock Report on AHR

American Healthcare REIT Profile

(Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Read More

Institutional Ownership by Quarter for American Healthcare REIT (NYSE:AHR)

Should You Invest $1,000 in American Healthcare REIT Right Now?

Before you consider American Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.

While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines